Intimation for Closure of Trading Window for the Year ended March 31, 2025

Press Release – Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter year ended December 31, 2024

Integrated Filing (Financials) Dated 14.02.2025

Outcome of Board Meeting dated 14.02.2025

Intimation for Amendment of Share Purchase Agreement (SPA) dated February 15, 2024, First Amendment letter dated July 04, 2024 and Memorandum of Understanding dated October 22, 2024, in relation to acquisition of stake in Saarathi Healthcare Private Limited

Outcome of Postal Ballot, Scrutinizer report and Voting results

Intimation of Receipt of In Principle Approval from National Stock Exchange of India Limited (NSE) in reference to proposed Rights Issue of Equity Shares

Non-applicability of Corporate Governance Report as per Regulation 27(2) of SEBI(LODR) Regulations, 2015

SDD Compliance Certificate for the Quarter Year Ended December 31,2024

Certificate under Regulation 76 of the SEBI (Depositories and Participants) Regualtions, 2018 for the Quarter Year Ended December 31, 2024